Pharmacokinetic drug interaction studies must consider pharmacological heterogeneity, use of repeated dosing, and translation into a message understandable to practicing clinicians.
Jose
J
de Leon
Edoardo
E
Spina
Francisco J
FJ
Diaz
D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards; D004334:Drug Administration Schedule; D004347:Drug Interactions; D017408:Guidelines as Topic; D006801:Humans; D008954:Models, Biological; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000378:metabolism; D010599:Pharmacokinetics; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations